07:00 , Aug 27, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact nformation Pulmonary disease Idiopathic pulmonary fibrosis (IPF) NADPH oxidase 4 (NOX4); transforming growth factor-b1 (TGFB1); actin-a1 skeletal muscle (ACTA1) Studies in cell culture and in mice suggest...
07:00 , Jun 18, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Musculoskeletal disease Nemaline myopathy Actin-a1 skeletal muscle (ACTA1); actin-a cardiac muscle 1 (ACTC1) A study in mice suggests that activation of ACTC1 expression could help...